The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Why a $6 Million Credit Fund Bet Makes Sense With a 13% Yield on the Table FS Credit Opportunities Corp. is a closed-end fund specializing in global credit investments and event-driven strategies.
e.l.f. Beauty Stock Is Off to a Hot Start to 2026. Will It Continue? The cosmetics stock has blown past the S&P 500 during the first few weeks of the year.
Why Microsoft Stock Dropped This Week The tech titan loss hundreds of billions of dollars of market value.
Affiance Financial Bets $43 Million on Chuck Akre's "Compounding Machines" ETF AKRE is a concentrated ETF emphasizing high-quality U.S. equities and disciplined stock selection.
SJS Investment Boosts Ultra-Short Treasury Position by $6.39 Million This ETF provides exposure to ultra-short-term U.S. Treasury bills, aiming for liquidity and minimal interest rate risk.
NuScale Power Under $20: Your Last Chance to Buy? NuScale Power has a novel technology that can disrupt a sleepy industry. Is today's price a buying window?
Better Creative Tools Stock: Figma vs. Adobe The creative software rivals are both publicly traded now. One is a cash machine, the other a growth rocket.
2 Electric Vehicle Stocks That Could Make You Rich... Slowly Here are two hidden gems in the electric vehicle industry that could make investors wealthy over the long haul.
ConocoPhillips and Trump's Venezuela Play: Is This a Hidden Catalyst or Just More Noise for Investors? ConocoPhillips stock is soaring to start 2026, but investors have other reasons to consider this oil giant beyond Venezuela.
Forget AI Stocks: This REIT Could Be Your Ticket to AI Profits Prologis can make a lot of money developing AI data centers over the coming decade.
The Best Stocks to Invest $500 in This February There are plenty of strong growth and value stocks available to buy right now.
This Security Leader Is Turning Surging Cyber Threats Into Recurring Revenue Palo Alto Networks is emerging as a leader in cybersecurity and one of the best growth stocks on the market.
2 Monster Stocks to Hold for the Next 20 Years -- Including Microsoft (MSFT) Stock These stocks have grown at an average annual rate of around 24% to 25% over the past decade, with plenty of room to keep growing.
1 Nuclear Stock That Could Power Your Retirement Income for Decades This company will help lead the charge toward America's bright nuclear future.
Is the YieldMax MSTR Option Income Strategy ETF an Underrated Crypto Play? The YieldMax MSTR Option Income Strategy ETF has a huge yield and is focused solely on Strategy Inc.
1 Unstoppable Vanguard ETF That Could Crush the S&P 500 (Again) in 2026 Technology stocks are likely to continue leading the broader market higher in 2026, fueled by the artificial intelligence boom.
Silver's Up 17% in 1 Month: 3 Stocks to Ride the Surge Even after Friday's sell-off, silver had a big January -- and its path to fresh gains is clear.
Time to Buy Ford Stock? Not Until These 2 Things Change. There are a number of valid reasons Ford is an attractive long-term investment, but it must fix these two things for investors.
How Much Higher Can Micron Stock Go? Micron stock has gained 327% over the last 12 months thanks to soaring demand for memory from data center operators.
3 Dates for Disney Stock Investors to Circle in February The entertainment bellwether has a telltale financial update coming sooner than you think.
4 Signs You Should Relocate in Retirement It's not easy to uproot yourself in retirement, but it may be the best solution in certain circumstances.
Is It Too Late to Buy This Surging Silver ETF? The iShares Silver Trust recently hit a new all-time high.
The Best Tech ETF to Invest $2,000 in Right Now This ETF has tech companies leading the way with a built-in hedge.
2 Cathie Wood Stocks to Buy on the Dip See beyond the near-term headwinds and focus on the long-term upside.
Alphabet vs. Amazon: Which One Will Make You Richer? Both of these stocks look like exceptional AI-powered picks in 2026.
Could This Beaten-Down AI Stock Stage the Comeback of 2026? Samsara's stock had a rough go of things in 2025, despite the fact that the company is growing fast and operates in a fast-growing industry.
Is It Time to Buy This Historically Cheap E-Commerce Stock? (Hint: It's Not Amazon) Given that online shopping is a durable secular trend, it makes sense why investors want to allocate capital to this sector.
1 Top ETF I Plan to Load Up on This Month This ETF delivers a growing stream of dividend income.
Should You Buy Archer Aviation While It's Below $8? Archer's share price has soared over the past three years, but there are some significant red flags with this stock.
3 Easiest Ways to Boost Your Social Security Benefits For millions of Americans, Social Security benefits represent a financial lifeline. Here's how you can make the most of yours.
This AI Stock Could Be Your Best Shot at Life-Changing Gains A cheap valuation and stunning growth make this AI stock worth buying hand over fist before it soars higher.
2 No-Brainer Warren Buffett Stocks to Buy Right Now You can take a set-it-and-forget-it approach with these two industry leaders.
Is GameStop the Next Berkshire Hathaway? Since becoming CEO, Ryan Cohen has redefined GameStop's business and invested company funds outside of retailing.
Prediction Markets Are the Hot New Thing, but Will They Be a Good Long-Term Investment? Prediction markets offer a unique way to make money, even if top cryptocurrencies are in the red.
Here's Why You'll Probably Never Hit a 'Perfect' 850 Credit Score Achieving a perfect 850 credit score takes decades. But you can copy the same habits and still get top loan rates and credit cards.
Here's Why Pfizer Stock Is Still a Buy Pfizer has fallen behind the pack when it comes to GLP-1 drugs, but the company is still fighting.
